Elaborated survey in the scope of nanocarriers engineering for boosting chemotherapy cytotoxicity: A meta-analysis study
Sally Safwat; Rania Hathout; Aziz Ishak, Rania; Nahed Mortada;
Abstract
Cancer is the prime cause of mortality throughout the world. Although the conventional chemotherapeutic agents damage the cancerous cells, they exert prominent injury to the normal cells owing to their lack of specificity. With advances in science, many research studies have been established to boost the cytotoxic effect of the chemotherapeutic agents via innovating novel nano-formulations having different variables. In the current meta-analysis study, combined data from different research articles were gathered for the evidence-based proof of the superiority of drug loaded nanocarriers over their corresponding conventional solutions in boosting the cytotoxic effect of chemotherapy in terms of IC50 values. The meta-analysis was subdivided into three subgroups; nanoparticles versus nanofibers, surface functionalized nanocarriers versus naked ones, and protein versus non-protein-based platforms. The different subgroups interestingly showed distinct scoring outcome data paving the road for cytotoxicity enhancement of the anti-cancer drugs in an evidence-based manner.
Other data
Title | Elaborated survey in the scope of nanocarriers engineering for boosting chemotherapy cytotoxicity: A meta-analysis study | Authors | Sally Safwat; Rania Hathout; Aziz Ishak, Rania ; Nahed Mortada | Keywords | Nanocarriers;Nanoparticles;Nanofibers;Functionalized;Non-functionalized;Protein-based;Non-protein-based;Cytotoxicity study;Meta-analysis | Issue Date | 15-Dec-2021 | Publisher | Elsevier | Journal | International Journal of Pharmaceutics | Volume | 610 | Start page | 121268 | DOI | https://doi.org/10.1016/j.ijpharm.2021.121268 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.